Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS)
- 6 February 2015
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 32 (5) , 609-617
Abstract
Aims: To investigate the best glucose monitoring strategy for maintaining euglycaemia by comparing self‐monitoring of blood glucose with continuous glucose monitoring, with or without an alarm function.Methods: A 100‐day, randomized controlled study was conducted at four European centres, enrolling 160 patients with Type 1 or Type 2 diabetes, on multiple daily insulin injections or continuous subcutaneous insulin infusion. Participants were randomized to continuous glucose monitoring without alarms (n = 48), continuous glucose monitoring with alarms (n = 49) or self‐monitoring of blood glucose (n = 48).Results: Time spent outside the glucose target during days 80–100 was 9.9 h/day for the continuous glucose monitoring without alarms group, 9.7 h/day for the continuous glucose monitoring with alarms group and 10.6 h/day for the self‐monitoring of blood glucose group (P = 0.18 and 0.08 compared with continuous glucose monitoring without and with alarms, respectively).The continuous glucose monitoring with alarms group spent less time in hypoglycaemia compared with the self‐monitoring of blood glucose group (1.0 h/day and 1.6 h/day, respectively; 95% CI −1.2 to −0.1; P = 0.030). Among those treated with continuous subcutaneous insulin infusion, time spent outside the glucose target was significantly different when comparing continuous glucose monitoring without alarms and self‐monitoring of blood glucose (−1.9 h/day; 95% CI −3.8 to 0.0; P = 0.0461) and when comparing continuous glucose monitoring with alarms and self‐monitoring of blood glucose (−2.4 h/day; 95% CI −4.1 to −0.5; P = 0.0134). There was no difference in HbA1c reduction from baseline in the three groups; however, the proportion of participants with a reduction of ≥ 6 mmol/mol (≥ 0.5%) was higher in the continuous glucose monitoring without alarms (27%) and continuous glucose monitoring with alarms groups (25%) than in the self‐monitoring of blood glucose group (10.6%).Conclusions: This study shows that the use of continuous glucose monitoring reduces time spent outside glucose targets compared with self‐monitoring of blood glucose, especially among users of insulin pumps.Keywords
Funding Information
- Abbott Laboratories
This publication has 24 references indexed in Scilit:
- Continuous Glucose Monitoring: Current Use and Future DirectionsCurrent Diabetes Reports, 2013
- Efficacy of Continuous Glucose Monitoring in Improving Glycemic Control and Reducing Hypoglycemia: A Systematic Review and Meta-Analysis of Randomized TrialsJournal of Diabetes Science and Technology, 2011
- Methods of Evaluating the Utility of Continuous Glucose Monitor AlertsJournal of Diabetes Science and Technology, 2010
- Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 DiabetesDiabetes Care, 2009
- Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trialDiabetologia, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 DiabetesNew England Journal of Medicine, 2008
- Sensor-Augmented Insulin Pump Therapy: Results of the First Randomized Treat-to-Target StudyDiabetes Technology & Therapeutics, 2008
- Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose MonitoringDiabetes Care, 2006
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993